©2026 Business Next Media Corp. All Rights Reserved. No.102, Guangfu S. Rd., Da'an Dist., Taipei City 106, Taiwan
Taiwanese Startup iPreg’s Sperm Sorting Chip is the Game-Changer in IVF Market
iPreg Incorporation introduces the “Sperm Sorting Chip'' with the goals of increasing the fertility rate and addressing a gap in the current In Vitro Fertilization (IVF) process. It replaces the traditional technique of sperm isolation to boost the current rate of success achieved in IVF procedures. iPreg Inc. is a global biomedical device manufacturer in the field of reproductive medicine. Its main services focus is on the in vitro fertilization market and the continuous improvement of new-generation sperm sorting methods.
Pregnancy is not as easy as you might think
The current infertility rate is approximately 15% globally, IVF is the most efficient solution on the market, with the ability to increase the pregnancy rate to 37.4%. One of the weaknesses of IVF is inefficient sperm selection using traditional sperm sorting processes. In fact, these processes cannot avoid DNA fragmentation in sperm, which may reduce the success rate for IVF pregnancy therapies.
The iPreg Sperm Sorting Chip is designed using hydromechanics technology. The R&D team conducted research on the swimming behaviors of human sperm, with results showing that the swimming behaviors of healthy (normal) sperm and abnormal sperm are noticeably different. The team used the fluid mechanics of sperm swimming in the microfluidic chip to create an environment that allows sperm to race in the chip. The uniquely designed chip can increase the purity of healthy sperm up to 90% with minimal DNA damage.
High rates of success at a competitive price
The iPreg Sperm Sorting Chip has proven its ability to increase the healthy sperm ratio to 90% in 15 minutes. Therefore, it plays a role in assisting reproduction by accelerating the crucial stage of sperm screening in IVF. Through the stages of fertility, starting from increasing the ratio of healthy sperm to the formation of the blastocyst, the iPreg Sperm Sorting Chip is expected to enhance the overall success of pregnancy.
In comparison with the traditional centrifugation method and other products, iPreg Sperm Sorting Chip hits the mark in multiple categories: high efficiency, purity, and DNA integrity. It requires the least time, with a minimum of 15 minutes. Moreover, it also maintains a 90% level of purity in progressive sperm and is available at a competitive price.
Expanding from Taiwan to the world with patents
iPreg was founded by Dr. CY Chung, who holds a Ph.D. in Immunology, together with his mentor, Dr. MI Hsu, and a team of gynecology specialists. The team has worked with external partners such as the Taiwan IVF Group and Chiao Tung University in the development process. iPreg Inc. is looking forward to a progressive future. In 2019 - 2020, iPreg Inc. was in the manufacturing, patent application, and FDA approval stage of its business. In 2020, iPreg Inc. expanded into the China market, and will expand into South East Asia and North America in 2021 and Europe in 2023. iPreg Inc. secured two invention patents in 2019: M588247/TW and I684753/TW. Three other patents are currently under review in Taiwan and the United States. In the meantime, iPreg Inc. will work closely with CFDA (NMPA), FDA, and CE to approve of the Sperm Sorting Chip to ensure that its safety, health, and environmental protection measures meet government requirements.
iPreg Sperm Sorting Chip’s performance in efficiency, safety, and quality may be the crucial piece of the puzzle needed to effectively streamline the IVF process. Because of its potentially significant impact on IVF, iPreg was selected by Taiwan Tech Arena (TTA) as one of the 100 featured Taiwanese startups showcased at CES 2021.
Official website：https://www.ipreginc.com/
©2026 Business Next Media Corp. All Rights Reserved. No.102, Guangfu S. Rd., Da'an Dist., Taipei City 106, Taiwan